CA Stock MarketDetailed Quotes

CLAS Claritas Pharmaceuticals Inc

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayMarket Closed Jul 12 09:30 ET
0Market Cap0.00P/E (TTM)

Claritas Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
Assets
Current assets
Cash, cash equivalents and short term investments
-99.59%2K
2,463.64%282K
833.33%28K
-84.38%5K
-84.38%5K
1,480.65%490K
-98.66%11K
-97.89%3K
-85.90%32K
-85.90%32K
-Cash and cash equivalents
-99.59%2K
2,463.64%282K
833.33%28K
-84.38%5K
-84.38%5K
1,480.65%490K
-98.66%11K
-97.89%3K
-85.90%32K
-85.90%32K
-Other receivables
----
----
5.50%4.28M
29.66%4.22M
29.66%4.22M
25.82%4.17M
18.07%4.11M
19.93%4.06M
-24.04%3.26M
-24.04%3.26M
Holding assets for sale
--5.33M
--5.33M
----
----
----
----
----
----
----
----
Total current assets
1,581.98%11.02M
7,805.67%11.15M
894.12%1.18M
537.25%975K
537.25%975K
-23.93%655K
-91.12%141K
-84.26%119K
-79.52%153K
-79.52%153K
Non current assets
-Long term equity investment
-85.51%10K
920.59%694K
----
----
----
-82.17%69K
-81.27%68K
----
--373K
--373K
-Goodwill
----
----
-72.35%6.92M
-62.29%9.46M
-62.29%9.46M
-72.78%9.68M
-61.11%12.94M
-57.89%25.03M
-57.37%25.09M
-57.37%25.09M
Regulatory assets
-38.18%102K
-21.54%102K
-6.90%108K
70.25%206K
70.25%206K
-79.55%165K
-82.48%130K
-81.11%116K
-76.73%121K
-76.73%121K
Liabilities
Current liabilities
Current debt and capital lease obligation
-34.87%538K
-28.68%542K
-41.16%406K
154.82%925K
154.82%925K
153.37%826K
155.89%760K
13.49%690K
47.56%363K
47.56%363K
-Current debt
-34.87%538K
-28.68%542K
-41.16%406K
154.82%925K
154.82%925K
153.37%826K
155.89%760K
13.49%690K
47.56%363K
47.56%363K
-accounts payable
-57.06%371K
-70.90%417K
-27.90%951K
-41.94%908K
-41.94%908K
-12.46%864K
55.25%1.43M
-15.66%1.32M
-5.56%1.56M
-5.56%1.56M
-Total tax payable
-99.46%10K
-79.93%694K
-82.58%1.3M
-92.11%1.81M
-92.11%1.81M
-92.82%1.84M
-85.85%3.46M
-83.78%7.43M
-45.44%22.93M
-45.44%22.93M
-Other payable
-98.72%7K
60.00%8K
-54.55%5K
-25.00%6K
-25.00%6K
--546K
-98.61%5K
--11K
--8K
--8K
Current accrued expenses
4.34%961K
0.92%877K
46.42%1M
85.47%1.07M
85.47%1.07M
-35.00%921K
6.63%869K
-62.13%685K
-56.54%578K
-56.54%578K
Current liabilities
14.11%7.73M
7.35%7.7M
-1.64%6.64M
23.71%7.13M
23.71%7.13M
12.18%6.78M
30.02%7.17M
-8.33%6.75M
-26.32%5.76M
-26.32%5.76M
Non current liabilities
Derivative product liabilities
----
----
-99.87%1K
-98.55%40K
-98.55%40K
-97.57%60K
-63.43%1.07M
-24.93%789K
804.25%2.77M
804.25%2.77M
Long term provisions
-85.51%10K
920.59%694K
----
----
----
-82.17%69K
-81.27%68K
----
--373K
--373K
Total non current liabilities
-10.17%7.74M
-21.04%8.39M
-44.06%7.93M
-68.85%8.94M
-68.85%8.94M
-72.82%8.62M
-64.52%10.63M
-73.33%14.18M
-42.44%28.69M
-42.44%28.69M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Additional paid-in capital
10.13%62.35M
9.96%62.01M
2.18%57.48M
1.32%56.51M
1.32%56.51M
1,335.18%56.62M
1,427.19%56.4M
1,265.77%56.26M
16.77%55.78M
16.77%55.78M
Total equity
1.28%11.02M
-14.78%11.16M
-67.77%8.11M
-58.64%10.45M
-58.64%10.45M
-70.13%10.89M
-62.85%13.09M
-58.20%25.16M
-57.63%25.26M
-57.63%25.26M
(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019(Q4)Dec 31, 2019
Assets
Current assets
Cash, cash equivalents and short term investments -99.59%2K2,463.64%282K833.33%28K-84.38%5K-84.38%5K1,480.65%490K-98.66%11K-97.89%3K-85.90%32K-85.90%32K
-Cash and cash equivalents -99.59%2K2,463.64%282K833.33%28K-84.38%5K-84.38%5K1,480.65%490K-98.66%11K-97.89%3K-85.90%32K-85.90%32K
-Other receivables --------5.50%4.28M29.66%4.22M29.66%4.22M25.82%4.17M18.07%4.11M19.93%4.06M-24.04%3.26M-24.04%3.26M
Holding assets for sale --5.33M--5.33M--------------------------------
Total current assets 1,581.98%11.02M7,805.67%11.15M894.12%1.18M537.25%975K537.25%975K-23.93%655K-91.12%141K-84.26%119K-79.52%153K-79.52%153K
Non current assets
-Long term equity investment -85.51%10K920.59%694K-------------82.17%69K-81.27%68K------373K--373K
-Goodwill ---------72.35%6.92M-62.29%9.46M-62.29%9.46M-72.78%9.68M-61.11%12.94M-57.89%25.03M-57.37%25.09M-57.37%25.09M
Regulatory assets -38.18%102K-21.54%102K-6.90%108K70.25%206K70.25%206K-79.55%165K-82.48%130K-81.11%116K-76.73%121K-76.73%121K
Liabilities
Current liabilities
Current debt and capital lease obligation -34.87%538K-28.68%542K-41.16%406K154.82%925K154.82%925K153.37%826K155.89%760K13.49%690K47.56%363K47.56%363K
-Current debt -34.87%538K-28.68%542K-41.16%406K154.82%925K154.82%925K153.37%826K155.89%760K13.49%690K47.56%363K47.56%363K
-accounts payable -57.06%371K-70.90%417K-27.90%951K-41.94%908K-41.94%908K-12.46%864K55.25%1.43M-15.66%1.32M-5.56%1.56M-5.56%1.56M
-Total tax payable -99.46%10K-79.93%694K-82.58%1.3M-92.11%1.81M-92.11%1.81M-92.82%1.84M-85.85%3.46M-83.78%7.43M-45.44%22.93M-45.44%22.93M
-Other payable -98.72%7K60.00%8K-54.55%5K-25.00%6K-25.00%6K--546K-98.61%5K--11K--8K--8K
Current accrued expenses 4.34%961K0.92%877K46.42%1M85.47%1.07M85.47%1.07M-35.00%921K6.63%869K-62.13%685K-56.54%578K-56.54%578K
Current liabilities 14.11%7.73M7.35%7.7M-1.64%6.64M23.71%7.13M23.71%7.13M12.18%6.78M30.02%7.17M-8.33%6.75M-26.32%5.76M-26.32%5.76M
Non current liabilities
Derivative product liabilities ---------99.87%1K-98.55%40K-98.55%40K-97.57%60K-63.43%1.07M-24.93%789K804.25%2.77M804.25%2.77M
Long term provisions -85.51%10K920.59%694K-------------82.17%69K-81.27%68K------373K--373K
Total non current liabilities -10.17%7.74M-21.04%8.39M-44.06%7.93M-68.85%8.94M-68.85%8.94M-72.82%8.62M-64.52%10.63M-73.33%14.18M-42.44%28.69M-42.44%28.69M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
Additional paid-in capital 10.13%62.35M9.96%62.01M2.18%57.48M1.32%56.51M1.32%56.51M1,335.18%56.62M1,427.19%56.4M1,265.77%56.26M16.77%55.78M16.77%55.78M
Total equity 1.28%11.02M-14.78%11.16M-67.77%8.11M-58.64%10.45M-58.64%10.45M-70.13%10.89M-62.85%13.09M-58.20%25.16M-57.63%25.26M-57.63%25.26M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg